Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Looking for short term gigs? Discover where to find quick cash options that fit your schedule.
25,797 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Rocket Lab has surged more than 350% in a year, but investors remain split on the sustainability of the rally as back...
Memory changes in seniors may come from a reversible vitamin issue rather than dementia. Doctors say B12 deficiency c...
A broad market rebound centers on chipmakers like Micron and Nvidia, while SpaceX's IPO plans add a fresh twist to in...
In a crowded low Earth orbit, the real gains come from keeping satellites alive and productive. This article explains...
PNC Bank has closed a $251.4 million affordable housing fund to expand the nation’s supply of affordable rentals, fin...
A hypothetical spacex stock $2.5 trillion valuation invites big questions about revenue, profitability, and risk. Thi...
A biotech growth stock has surged 70% this year as it heads into pivotal phase 3 data and regulatory steps. Here’s wh...
May delinquencies rose modestly as calendar timing pushed some payments into June, but overall mortgage health remain...
Investors face a choice between a pharmaceutical powerhouse with proven earnings and a high-growth space company unde...
Tesla reports a robust quarter with deliveries around 515,000, topping expectations and reigniting investor optimism....
July began with AI-driven headlines shifting attention from headlines to execution. This guide breaks down how stock ...